Vascular Graft Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)

This report is segmented by Product, Application (Aneurysms, Kidney Failure, Vascular Occlusion, Coronary Artery Diseases, and Other Applications), Raw Material, and Geography.

Market Snapshot

 Vascular Graft Market Overview
Study Period: 2018 - 2026
Base Year: 2020
Fastest Growing Market: Asia Pacific
Largest Market: North America
CAGR: 5.7 %
 Vascular Graft Market Key Players

Need a report that reflects how COVID-19 has impacted this market and its growth?

Market Overview

A vascular graft is a surgical procedure that redirects blood flow from one area of the body to another by reconnecting the blood vessels. Key factors contributing to the market growth are rising prevalence of cardiac diseases, increasing prevalence of diabetes and end-stage renal diseases, coronary artery disease (CAD), hypertension, and cardiac aneurysms. Apart from the mentioned factors, genetic and hereditary factors, unhealthy lifestyle, alcohol consumption, and tobacco smoking, among others are expected to increase the demand for vascular grafts over the period. A low reimbursement rate and rising out-of-pocket expenses in an emerging economies can restrain market growth.

Scope of the Report

As per the scope of the report, Vascular grafts are medical devices used in vascular bypass procedures to direct the blood flow from one area to another by reconnecting the blood vessels.

By Product
Hemodialysis Access Graft
Endovascular Stent Graft
Peripheral Vascular Graft
Coronary Artery By-pass Graft
By Application
Kidney Failure
Vascular Occlusion
Coronary Artery Diseases
Other Applications
By Raw Material
Synthetic Raw Material
Biological Raw Material
North America
United States
United Kingdom
Rest of Europe
South Korea
Rest of Asia-Pacific
Middle-East and Africa
South Africa
Rest of Middle-East and Africa
South America
Rest of South America

Report scope can be customized per your requirements. Click here.

Key Market Trends

Application in Kidney Failure is Expected to Register Robust Growth

The global prevalence of end-stage renal diseases (ESRD) is high and increasing at a significant rate. In 2017, 697.5 million cases of all-stage CKD were recorded, for a global prevalence of 9.1%, as per Global Burden of Disease Study 2017. It is found that chronic kidney diseases (CKD) may develop over many years leading to ESRD and lead to kidney failure. As per a 2018 report by the L. Y. Wong et al., published in International Journal of Nephrology, from 2007 to 2017 increased from approximately 12% to 17% and is further expected to increase to approximately 24% by 2035.

Kidney Failure is treated by replacing kidney through a kidney transplant. This process uses vascular grafts. The renal vessel is reconstructed in kidney transplantation using vascular grafts. Hence, increasing incidence of end-stage kidney failure is expected to increase the demand for vascular grafts as well, which will help the growth of the market.

 Vascular Graft Market Key Trends

North America is Expected to Retain Largest Market Share During the Forecast Period

North America dominates the vascular graft market. North America maintained its dominant share due to the high prevalence rate of diabetes, cardiovascular diseases, and chronic kidney disease. Presence of reimbursement coverage and availability of state-of-the-art healthcare infrastructure are driving the growth of this market in North America.

Asia-Pacific is anticipated to show the fastest growth during the forecast period due to increasing incidences of cardiovascular disease and diabetes and improving healthcare infrastructure.

 Vascular Graft Market Growth by Region

Competitive Landscape

Key players in the market include Abbott Laboratories, B. Braun Melsungen AG, Bard Peripheral Vascular Inc. (BD), Cardinal Health (Cordis), Cook Medical, Cryolife, Getinge Group, LeMaitre Vascular Inc, Medtronic plc, Terumo Medical Corporation, and W.L. Gore & Associates Inc., among others.

Table of Contents


    1. 1.1 Study Deliverables

    2. 1.2 Study Assumptions

    3. 1.3 Scope of the Study




    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Increasing Prevalence of Lifestyle-related Disorders

      2. 4.2.2 Technological Advancements in the Scaffold Material and Design of Vascular Grafts

    3. 4.3 Market Restraints

      1. 4.3.1 Unfavorable Reimbursement Scenario

      2. 4.3.2 High Risk Associated with Graft Failures

    4. 4.4 Porter's Five Force Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry


    1. 5.1 By Product

      1. 5.1.1 Hemodialysis Access Graft

      2. 5.1.2 Endovascular Stent Graft

      3. 5.1.3 Peripheral Vascular Graft

      4. 5.1.4 Coronary Artery By-pass Graft

    2. 5.2 By Application

      1. 5.2.1 Aneurysms

      2. 5.2.2 Kidney Failure

      3. 5.2.3 Vascular Occlusion

      4. 5.2.4 Coronary Artery Diseases

      5. 5.2.5 Other Applications

    3. 5.3 By Raw Material

      1. 5.3.1 Synthetic Raw Material

      2. 5.3.2 Biological Raw Material

    4. 5.4 Geography

      1. 5.4.1 North America

        1. United States

        2. Canada

        3. Mexico

      2. 5.4.2 Europe

        1. Germany

        2. United Kingdom

        3. France

        4. Italy

        5. Spain

        6. Rest of Europe

      3. 5.4.3 Asia-Pacific

        1. China

        2. Japan

        3. India

        4. Australia

        5. South Korea

        6. Rest of Asia-Pacific

      4. 5.4.4 Middle-East and Africa

        1. GCC

        2. South Africa

        3. Rest of Middle-East and Africa

      5. 5.4.5 South America

        1. Brazil

        2. Argentina

        3. Rest of South America


    1. 6.1 Company Profiles

      1. 6.1.1 Abbott Laboratories

      2. 6.1.2 B. Braun Melsungen AG

      3. 6.1.3 Bard Peripheral Vascular Inc. (BD)

      4. 6.1.4 Cardinal Health (Cordis Corporation)

      5. 6.1.5 Cook Medical

      6. 6.1.6 Cryolife

      7. 6.1.7 Getinge Group

      8. 6.1.8 LeMaitre Vascular Inc

      9. 6.1.9 Medtronic PLC

      10. 6.1.10 Terumo Medical Corporation

      11. 6.1.11 W.L. Gore & Associates Inc

    2. *List Not Exhaustive

**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Vascular Graft Market market is studied from 2018 - 2026.

The Vascular Graft Market is growing at a CAGR of 5.7% over the next 5 years.

Asia Pacific is growing at the highest CAGR over 2021- 2026.

North America holds highest share in 2020.

Abbott Laboratories, Cook Medical, Terumo Medical Corporation, W.L. Gore & Associates Inc, LeMaitre Vascular Inc are the major companies operating in Vascular Graft Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!